1Neuro faces of beneficial T cells:essential in brain,impaired in aging and neurological diseases,and activated functionally by neurotransmitters and neuropeptidesMia Levite1165-11782Profiling neuroprotective potential of trehalose in animal models of neurodegenerative diseases:a systematic reviewKah Hui Yap, Shahrul Azmin, Suzana Makpol, Hanafi Ahmad Damanhuri, Muzaimi Mustapha, Jemaima Che Hamzah, Norlinah Mohamed Ibrahim1179-11853Cdk5 and aberrant cell cycle activation at the core of neurodegenerationRaquel Requejo-Aguilar1186-11904Recent advancements in noninvasive brain modulation for individuals with autism spectrum disorderJessica R.Griff, Jake Langlie, Nathalie B.Bencie, Zachary J.Cromar, Jeenu Mittal, Idil Memis, Steven Wallace, Alexander E.Marcillo, Rahul Mittal, Adrien A.Eshraghi1191-11955Vicious cycle of lipid peroxidation and iron accumulation in neurodegenerationIrene Villalón-García, Suleva Povea-Cabello, Mónica álvarez-Córdoba, Marta Talaverón-Rey, Juan M.Suárez-Rivero, Alejandra Suarez-Carrillo, Manuel Munuera-Cabeza, Diana Reche-López, Paula Cilleros-Holgado, Rocío Pi?ero-Pérez, José A.Sánchez-Alcázar1196-12026Cell-based therapeutic strategies for treatment of spinocerebellar ataxias:an updateJoana Sofia Correia, Sara Duarte-Silva, António José Salgado, Patrícia Maciel1203-12127Do tau-synaptic long-term depression interactions in the hippocampus play a pivotal role in the progression of Alzheimer's disease?Zhengtao Hu, Tomas Ondrejcak, Pengpeng Yu, Yangyang Zhang, Yin Yang, Igor Klyubin, Sean P.Kennelly, Michael J.Rowan, Neng-Wei Hu1213-12198Neurotrophic factor-based pharmacological approaches in neurological disordersMargherita Alfonsetti, Michele d'Angelo, Vanessa Castelli1220-12289Translational bioengineering strategies for peripheral nerve regeneration:opportunities,challenges,and novel conceptsKarim A.Sarhane, Chenhu Qiu, Thomas G.W.Harris, Philip J.Hanwright, Hai-Quan Mao, Sami H.Tuffaha1229-123410Decoding degeneration:the implementation of machine learning for clinical detection of neurodegenerative disordersFariha Khaliq, Jane Oberhauser, Debia Wakhloo, Sameehan Mahajani1235-124211Long-noncoding RNAs as epigenetic regulators in neurodegenerative diseasesPaola Ruffo, Francesca De Amicis, Emiliano Giardina, Francesca Luisa Conforti1243-124812The lymphatic system:a therapeutic target for central nervous system disordersJia-Qi Xu, Qian-Qi Liu, Sheng-Yuan Huang, Chun-Yue Duan, Hong-Bin Lu, Yong Cao, Jian-Zhong Hu1249-125613Plasticity of callosal neurons in the contralesional cortex following traumatic brain injuryAlexandra Chovsepian, Laura Empl, Florence M.Bareyre1257-125814Molecular mechanisms of lesion-induced axonal sprouting in the corticofugal projection:the role of glial cellsLeechung Chang, Nobuhiko Yamamoto1259-126015Targeting neuroinflammation after therapeutic hypothermia for perinatal hypoxic-ischemic brain injuryKelly Q.Zhou, Joanne O.Davidson1261-126216Ketamine,a trauma analgesic with sex-specific immunomodulatory functionHaley F.Spencer, Rina Y.Berman, Martin Boese, Kwang H.Choi1263-126417Neural regeneration research model to be explored:SH-SY5Y human neuroblastoma cellsLavynia Ferreira Hoffmann, Alexandre Martins, Fernanda Majolo, Ver?nica Contini, Stefan Laufer, Márcia Inês Goettert1265-126618cGMP signaling:a potential therapeutic target for neurodegeneration in glaucoma?Joseph M.Holden, Lauren K.Wareham1267-126819Putting PLX5622 into perspective:microglia in central nervous system viral infectionAlanna G.Spiteri, Nicholas J.C.King1269-127020Nature can still be the strongest help against aging and neurodegeneration:the sirtuins wayDavid Della-Morte, Francesca Pacifici1271-1272 